The Press Office provides journalists with information on the diverse range of subjects that are relevant to the pharmaceutical industry. Our role is to ensure that any type of media is able to have access to the industry perspective and opinion.
Chris Green MP and the ABPI Vaccine Group were joined yesterday evening by over 40 attendees at a Parliamentary reception in the House of Commons to mark World Immunisation Week. Attendees included Parliamentarians, policy makers, commissioners, patient organisations, professional groups and media. Read more
A new Advanced Therapy Manufacturing Taskforce has been launched by the Medicines Manufacturing Industry Partnership (MMIP) to secure the future of manufacturing advanced therapies in the UK.Read more
The Association of the British Pharmaceutical Industry has, for the first time, partnered with the Guardian University Awards to celebrate excellence and innovation in our higher education institutions. Read more
New figures out today from the Association of the British Pharmaceutical Industry, show that the pharmaceutical industry has contributed over £1billion to the Department of Health towards the cost of new medicines as part of the voluntary Pharmaceutical Payment Regulation Scheme (PPRS).Read more
As a member of the Rare Disease Forum, we welcome the latest report and its recognition of the role the pharmaceutical industry plays in tackling the challenges of Rare Diseases, from research to new medicines for patients. We also support the implementation of the UK Strategy for Rare Diseases as a core part of the Government’s broader strategy for Life Sciences.
“All medicines undergo rigorous testing for quality, safety and efficacy by global regulators, including the MHRA in the UK. The data is also subject to continuous scrutiny during trials, once licensed and throughout the life of the medicine, including after a patent has expired."
We are pleased to publish the report from the workshop on ‘Real world evidence’, held in partnership with the Academy of Medical Sciences.Read more
"The pharmaceutical industry is committed to working with healthcare professionals in order to develop medicines and deliver quality healthcare within the robust guidelines set out in the Code of Practice."Read more
As the consultation on the way forward for the Cancer Drugs Fund (CDF) closes, the Association of the British Pharmaceutical Industry (ABPI) urges the government to seize the opportunity and transform the way cancer medicines are assessed by the National Institute for Health and Care Excellence (NICE) and commissioned and funded by NHS England. If we do this, we can achieve a sustainable, affordable solution that will provide rapid access to new medicines for NHS patients.Read more
Mike Thompson has been appointed as Chief Executive of the ABPI, effective 1 March 2016.Read more